Related references
Note: Only part of the references are listed.Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase
Dana M. Gwinn et al.
CANCER CELL (2018)
xCT (SLC7A11)-mediated metabolic reprogramming promotes non-small cell lung cancer progression
Xiangming Ji et al.
ONCOGENE (2018)
The ferroptosis inducer erastin irreversibly inhibits system xc- and synergizes with cisplatin to increase cisplatin's cytotoxicity in cancer cells
Mami Sato et al.
SCIENTIFIC REPORTS (2018)
BAP1 links metabolic regulation of ferroptosis to tumour suppression
Yilei Zhang et al.
NATURE CELL BIOLOGY (2018)
18F-5-Fluoroaminosuberic Acid as a Potential Tracer to Gauge Oxidative Stress in Breast Cancer Models
Hua Yang et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT
Evan C. Lien et al.
SCIENCE SIGNALING (2017)
Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT
Evan C. Lien et al.
SCIENCE SIGNALING (2017)
Comparative analysis of antibodies to xCT (Slc7a11): Forewarned is forearmed
Joeri Van Liefferinge et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2016)
The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)
Kenji Tsuchihashi et al.
CANCER RESEARCH (2016)
Mutant KRAS Enhances Tumor Cell Fitness by Upregulating Stress Granules
Elda Grabocka et al.
CELL (2016)
Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
Emma M. Kerr et al.
NATURE (2016)
NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
Hui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Glutathione and Thioredoxin Antioxidant Pathways Synergize to Drive Cancer Initiation and Progression
Isaac S. Harris et al.
CANCER CELL (2015)
Differential Requirements for eIF4E Dose in Normal Development and Cancer
Morgan L. Truitt et al.
CELL (2015)
Oxidative stress inhibits distant metastasis by human melanoma cells
Elena Piskounova et al.
NATURE (2015)
Ferroptosis as a p53-mediated activity during tumour suppression
Le Jiang et al.
NATURE (2015)
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Jihye Yun et al.
SCIENCE (2015)
Antioxidants can increase melanoma metastasis in mice
Kristell Le Gal et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
IGF-I Regulates Redox Status in Breast Cancer Cells by Activating the Amino Acid Transport Molecule xC
Yuzhe Yang et al.
CANCER RESEARCH (2014)
Oncogenic KRAS Confers Chemoresistance by Upregulating NRF2
Shasha Tao et al.
CANCER RESEARCH (2014)
Novel signaling axis for ROS generation during K-Ras-induced cellular transformation
M-T Park et al.
CELL DEATH AND DIFFERENTIATION (2014)
Functional Imaging of Oxidative Stress with a Novel PET Imaging Agent, 18F-5-Fluoro-L- Aminosuberic Acid
Jack M. Webster et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome Inhibition
Peng Ye et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Glutamine Sensitivity Analysis Identifies the xCT Antiporter as a Common Triple-Negative Breast Tumor Therapeutic Target
Luika A. Timmerman et al.
CANCER CELL (2013)
xCT Inhibition Depletes CD44v-Expressing Tumor Cells That Are Resistant to EGFR-Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Momoko Yoshikawa et al.
CANCER RESEARCH (2013)
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Jaekyoung Son et al.
NATURE (2013)
A Comprehensive Survey of Ras Mutations in Cancer
Ian A. Prior et al.
CANCER RESEARCH (2012)
The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis
T. L. Ng et al.
CELL DEATH AND DIFFERENTIATION (2012)
Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia
Wan Zhang et al.
NATURE CELL BIOLOGY (2012)
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation
C. E. Tognon et al.
ONCOGENE (2012)
CD44 Variant Regulates Redox Status in Cancer Cells by Stabilizing the xCT Subunit of System xc- and Thereby Promotes Tumor Growth
Takatsugu Ishimoto et al.
CANCER CELL (2011)
Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma
Weijie Guo et al.
CANCER LETTERS (2011)
Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis
Jessie Yanxiang Guo et al.
GENES & DEVELOPMENT (2011)
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
Gina M. De Nicola et al.
NATURE (2011)
RAS oncogenes: weaving a tumorigenic web
Yuliya Pylayeva-Gupta et al.
NATURE REVIEWS CANCER (2011)
Phosphorylation of the Transcription Factor Ets-1 by ERK2: Rapid Dissociation of ADP and Phospho-Ets-1
Kari Callaway et al.
BIOCHEMISTRY (2010)
Genetic analysis of Ras signalling pathways in cell proliferation, migration and survival
Matthias Drosten et al.
EMBO JOURNAL (2010)
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Frank Weinberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Association of reactive oxygen species levels and radioresistance in cancer stem cells
Maximilian Diehn et al.
NATURE (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
Redox imbalance in cystine/glutamate transporter-deficient mice
H Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element
LA Wilson et al.
FASEB JOURNAL (2005)
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
DA Eberhard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance
Y Huang et al.
CANCER RESEARCH (2005)
Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation
H Sato et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation
J Mitsushita et al.
CANCER RESEARCH (2004)
Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
W Jin et al.
BRITISH JOURNAL OF CANCER (2003)
Targeting ras signalling pathways in cancer therapy
J Downward
NATURE REVIEWS CANCER (2003)
Electrophile response element-mediated induction of the cystine/glutamate exchange transporter gene expression
H Sasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
AP-1 in cell proliferation and survival
E Shaulian et al.
ONCOGENE (2001)
Share Paper
